Articles on Big Pharma

Displaying 41 - 60 of 68 articles

Designed for other uses. Phil and Pam

Ohio execution: lethal injections are based on guesswork

Ever since the time of the guillotine, doctors have been at the centre of the death penalty. Joseph Guillotin, the physician who suggested the device be used in 18th-century France, was actually against…
Big pharma: a world of many faces. Greg Peverill-Conti

Glaxo: the new modern face of big pharma?

With billions to be made on the back of ill health and notable scandals and cover-ups in its history, it’s fair to say that many see the public face of the pharmaceutical industry as a mask for darker…
Drug companies vigorously seek to influence government policy. Ian Wilson

Tinsel or transparency? GlaxoSmithKline’s marketing overhaul

GlaxoSmithKline, one of the Big Five global pharmaceutical companies, this week gave the world an overdue Christmas present. Glaxo will stop paying doctors to promote its drugs and will no longer pay its…
A large proportion of drug trial data never gets published, skewing our picture of drugs’ effectiveness and safety. opensource.com

Making all clinical data public is vital for better medical care

An article published in the journal of the British Medical Association, BMJ, earlier this week illustrates a devastating problem with the “evidence base” in the academic medical literature. A large proportion…
The scandal started with allegations that GlaxoSmithKline had made illegal payments to doctors and government officials. Ian Wilson

China’s pharma scandal and the ethics of the global drug market

China is in the midst of conducting a series of corruption investigations of pharmaceutical companies that have been operating in the country. It all started with the investigation of officials from pharmaceutical…
Roche has refused to share clinical trial data for Tamiflu, which is used to relieve symptoms and reduce complications of influenza. AAP/Joe Castro

Remove industry bias from clinical trials before it’s too late

A study published today shows that clinical trials with industry sponsorship report greater benefits and fewer harmful side effects. In the discussion, the authors note that most reviews and guidelines…
Pathology service providers should be encouraged to adopt a code of conduct similar to that of Medicines Australia. Waiting room image from shutterstock.com

Small step for transparency in medicine but what about pathology?

You’ve probably given little thought to the slip of paper your GP hands you when she sends you off for a blood test. After all, you’re likely to have more important things to worry about. But the next…
Pharmaceutical companies undertake clinical trials to determine whether a potential new drug meets the requirements for market authorisation. Chain of figures photo from www.shutterstock.com

How to get drug companies to put needs before profits

New medicines must be approved as safe, efficacious and of good quality before they can be prescribed. But authors of two recent articles in the British Medical Journal argue that governments should introduce…
Medical experts say more transparency is needed in financial dealings between big drug companies and doctors. Flickr/e-MagineArt.com

Code for pharmaceutical industry ‘falls short’

Pharmaceutical companies will be required to disclose more details about their financial ties to doctors under a revised…
Drug prices reduce dramatically when large multinationals’ monopoly is broken. m.p.3./Flickr

Big Pharma in legal battles for monopoly prices in India

Two large multinational pharmaceutical companies are fighting for patents and monopoly pricing in Indian courts. The outcomes of the cases – involving Novartis and Bayer – are likely to determine the country’s…
SKB knew eight adolescents self-harmed or reported emergent suicidal ideas compared to only one in the placebo group but hid this. Michael Valli

Insight into how pharma manipulates research evidence: a case study

TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
If there are legitimate reasons for drug companies to gift doctors, then it should be disclosed. Steven Depolo/Flickr

Gifts that keep on giving: pharma should disclose all links to doctors

How would you feel if your local GP or specialist was pocketing money from a drug company to promote its products? If your gut tells you that this falls squarely into the category of Very Bad Ideas then…
Pharmaceutical companies are working in partnership with academia to bring drug candidates to clinical development. Spark/Flickr

New drug buddies: pharma turns to academia for medicines pipeline

The 2008 global financial crisis and an impending “patent cliff” have had a profound impact on the profitability of the pharmaceutical industry – they have made it change how it works. So, to maintain…
Repositioning a drug affords pharmaceutical companies the opportunity to enhance the return on their initial investment. bitzi/flickr

Teaching old drugs new tricks: why companies reposition medicines

Many pharmaceutical companies are having to re-examine their product portfolio because of the difficult economic climate. New uses for established drugs affords a way for these companies to maximise financial…

Top contributors

More